Mary Eileen Dolan to Real-Time Polymerase Chain Reaction
This is a "connection" page, showing publications Mary Eileen Dolan has written about Real-Time Polymerase Chain Reaction.
Connection Strength
0.137
-
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients. Clin Pharmacol Ther. 2014 Jun; 95(6):644-52.
Score: 0.111
-
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Nat Commun. 2013; 4:1393.
Score: 0.026